首页> 外文期刊>Molecular cancer research: MCR >Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
【24h】

Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.

机译:Sec5和Exo84促进致癌性ras介导的肿瘤发生。

获取原文
获取原文并翻译 | 示例
           

摘要

The genes encoding the Ras family of small GTPases are mutated to yield constitutively active GTP-bound oncogenic proteins in one third of all human cancers. Oncogenic Ras binds to and activates a number of proteins that promote tumorigenic phenotypes, including the family of Ral guanine nucleotide exchange factors (RalGEF). Activated RalGEFs convert the Ral family of small GTPases, composed of RalA and RalB, from an inactive GDP-bound state to an active GTP-bound state. As both RalA and RalB have been implicated in a variety of tumorigenic phenotypes, we sought to determine which proteins downstream of Rals promote transformation and tumorigenesis. Here, we report that shRNA-mediated knockdown of the Ral effector proteins Sec5 and Exo84, but less so in the case of RalBP1, reduced oncogenic RalGEF-mediated transformation and oncogenic Ras-driven tumorigenic growth of human cells. These results suggest that Rals promote oncogenic Ras-mediated tumorigenesis through, at least in part, Sec5 and Exo84.
机译:编码小GTP酶Ras家族的基因发生突变,从而在所有人类癌症的三分之一中产生组成型活性GTP结合致癌蛋白。致癌性Ras结合并激活多种促进致瘤表型的蛋白质,包括Ral鸟嘌呤核苷酸交换因子(RalGEF)家族。激活的RalGEF将由RalA和RalB组成的小GTP酶的Ral家族从非GDP绑定状态转换为GTP绑定状态。由于RalA和RalB均与多种致瘤表型有关,因此我们试图确定Ral下游的哪些蛋白可促进转化和肿瘤发生。在这里,我们报告说,shRNA介导的Ral效应蛋白Sec5和Exo84的敲低,但在RalBP1的情况下较少,减少了致癌的RalGEF介导的转化和致癌的Ras驱动的人细胞致瘤性生长。这些结果表明,Rals通过至少部分地通过Sec5和Exo84促进致癌性Ras介导的肿瘤发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号